[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 230
Citations 0
Correction
June 2018

Missing Funding Information

JAMA Neurol. 2018;75(6):763. doi:10.1001/jamaneurol.2018.0748

In the Original Investigation titled “Progression in the LRRK2-Associated Parkinson Disease Population,”1 published online January 8, 2018, and in the March print issue, the Funding/Support section was omitted. The following statement should have been included: “This study was funded by the Michael J. Fox Foundation for Parkinson’s Research and the National Institutes of Health (grants NINDS-K02NS073836, R56NS036630, K02NS080915, NS050487, NS060113, UL1 TR000040, UL1 RR024156, 10628097, and 1U01NS094148-01), as well as by grants from the Tel Aviv Sourasky Medical Center Grant of Excellence, the Khan Foundation, and the Israel Science Foundation Heritage Legacy.” In addition, the Role of the Funder/Sponsor section was omitted. The following statement should have been included: “The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.” This article was corrected online.

References
1.
Saunders-Pullman  R, Mirelman  A, Alcalay  RN,  et al; LRRK2 Ashkenazi Jewish Consortium.  Progression in the LRRK2-associated Parkinson disease population.  JAMA Neurol. 2018;75(3):312-319. doi:10.1001/jamaneurol.2017.4019PubMedGoogle ScholarCrossref
×